Intensive Serum Urate Lowering With Oral Urate‐Lowering Therapy for Erosive Gout: A Randomized Double‐Blind Controlled Trial

医学 双盲 痛风 尿酸 内科学 随机对照试验 高尿酸血症 病理 安慰剂 替代医学
作者
Nicola Dalbeth,Anthony Doyle,Karen Billington,Greg Gamble,Paul Tan,Kieran Latto,Thrishila Parshu Ram,Ravi Narang,Rachel Murdoch,David Bursill,Borislav Mihov,Lisa K. Stamp,Anne Horne
出处
期刊:Arthritis & rheumatology [Wiley]
卷期号:74 (6): 1059-1069 被引量:24
标识
DOI:10.1002/art.42055
摘要

Objective To determine whether a therapeutic approach of intensive serum urate lowering results in improved bone erosion scores in patients with erosive gout. Methods We undertook a 2‐year, double‐blind randomized controlled trial of 104 participants with erosive gout who were receiving serum urate–lowering therapy orally and who had serum urate levels of ≥0.30 mmoles/liter at baseline. Participants were randomly assigned to either an intensive serum urate target of <0.20 mmoles/liter or a standard target of <0.30 mmoles/liter (considered the standard according to rheumatology guidelines). Oral serum urate–lowering therapy was titrated to target using a standardized protocol (with the maximum approved doses of allopurinol, probenecid, febuxostat, and benzbromarone). The primary end point was the total computed tomography (CT) bone erosion score. Outcome Measures in Rheumatology (OMERACT) gout core outcome domains were secondary end points. Results Although the serum urate levels were significantly lower in the intensive target group compared to the standard target group over the study period ( P = 0.002), fewer participants in the intensive target group achieved the randomized serum urate target level by year 2 (62% versus 83% of patients in the standard target group; P < 0.05). The intensive target group required higher doses of allopurinol (mean ± SD 746 ± 210 mg/day versus 497 ± 186 mg/day; P < 0.001) and received more combination therapy ( P = 0.0004) compared to the standard target group. We observed small increases in CT bone erosion scores in both serum urate target groups over 2 years, with no between‐group difference ( P = 0.20). OMERACT core outcome domains (gout flares, tophi, pain, patient's global assessment of disease activity, health‐related quality of life, and activity limitation) improved in both groups over 2 years, with no between‐group differences. Adverse event and serious adverse event rates were similar between the groups. Conclusion Compared to a serum urate target of <0.30 mmoles/liter, more intensive serum urate lowering is difficult to achieve with an oral urate‐lowering therapy. Intensive serum urate lowering leads to a high medication burden and does not improve bone erosion scores in patients with erosive gout.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
WangSiwei完成签到,获得积分10
1秒前
4秒前
4秒前
加菲丰丰应助无语采纳,获得20
7秒前
自觉的向日葵完成签到,获得积分10
8秒前
龅牙苏发布了新的文献求助10
8秒前
阿超完成签到 ,获得积分10
8秒前
小周发布了新的文献求助10
8秒前
9秒前
12秒前
大个应助YOUNG采纳,获得10
13秒前
龅牙苏完成签到,获得积分10
14秒前
15秒前
赤元晶则发布了新的文献求助10
15秒前
16秒前
mov完成签到,获得积分10
16秒前
sunwen完成签到,获得积分10
16秒前
17秒前
哈哈完成签到,获得积分10
18秒前
Rondab应助霸气谷蕊采纳,获得10
18秒前
Aurora完成签到,获得积分10
18秒前
是瓜瓜不完成签到,获得积分10
19秒前
zxldylan完成签到,获得积分10
19秒前
yjwang发布了新的文献求助10
20秒前
落后冬云发布了新的文献求助10
20秒前
22秒前
adasdad完成签到 ,获得积分10
22秒前
NexusExplorer应助00采纳,获得10
23秒前
小蘑菇应助LL采纳,获得10
23秒前
momo完成签到,获得积分10
23秒前
24秒前
在水一方应助科研通管家采纳,获得10
24秒前
JamesPei应助科研通管家采纳,获得10
24秒前
Akim应助科研通管家采纳,获得10
24秒前
Orange应助科研通管家采纳,获得10
24秒前
24秒前
24秒前
24秒前
24秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971644
求助须知:如何正确求助?哪些是违规求助? 3516269
关于积分的说明 11181862
捐赠科研通 3251441
什么是DOI,文献DOI怎么找? 1795889
邀请新用户注册赠送积分活动 876131
科研通“疑难数据库(出版商)”最低求助积分说明 805246